APA (7th ed.) Citation

Tan, Q., Chi, Y., Su, M., Zhou, J., Zhou, D., Zheng, F., . . . Li, H. (2023). Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer. Frontiers in Genetics, 14, . https://doi.org/10.3389/fgene.2023.1125970

Chicago Style (17th ed.) Citation

Tan, Qiaorui, et al. "Potential Predictive Value of Circulating Tumor DNA (ctDNA) Mutations for the Efficacy of Immune Checkpoint Inhibitors in Advanced Triple-negative Breast Cancer." Frontiers in Genetics 14 (2023). https://doi.org/10.3389/fgene.2023.1125970.

MLA (9th ed.) Citation

Tan, Qiaorui, et al. "Potential Predictive Value of Circulating Tumor DNA (ctDNA) Mutations for the Efficacy of Immune Checkpoint Inhibitors in Advanced Triple-negative Breast Cancer." Frontiers in Genetics, vol. 14, 2023, https://doi.org/10.3389/fgene.2023.1125970.